» Articles » PMID: 9720519

Partial Nephrectomy for Renal Cell Carcinoma Can Achieve Long-term Tumor Control

Overview
Journal J Urol
Publisher Wolters Kluwer
Specialty Urology
Date 1998 Aug 28
PMID 9720519
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Partial nephrectomy is becoming more widely accepted as alternative treatment for small renal cell carcinoma. To analyze its value in tumor control and its complication rate a retrospective study was done.

Materials And Methods: A total of 76 patients underwent kidney sparing surgery, which was required in 25 and in the presence of a normal contralateral kidney in 51. Tumor size varied between 0.9 and 15 cm. Simple enucleation was done in 4 and partial nephrectomy in all other cases. The patients were followed every 3 months during year 1, every 4 months during years 2 and 3, and every 6 months during years 4 and 5 postoperatively. Mean followup is 75 months.

Results: Eight patients had postoperative complications, most often hemorrhage. None of the patients had local recurrence, although in 3 systemic disease developed.

Conclusions: Nephron sparing surgery is more challenging than radical nephrectomy and, therefore, can be more complicated. The selection of suitable candidates is the key to success. Many patients can benefit from nephron sparing surgery for small easily resectable renal cell carcinoma even in presence of a normal contralateral kidney. Randomized trials are needed to establish the definitive role of this approach in kidney cancer treatment.

Citing Articles

Evaluation of Parameters Affecting the Occurrence of Systemic Inflammatory Response Syndrome in Patients Operated on Due to Kidney Tumors.

Marcinek M, Tkocz M, Marczewski K, Partyka R, Kukulski L, Mlynarek-Sniezek K Biomedicines. 2023; 11(8).

PMID: 37626692 PMC: 10452910. DOI: 10.3390/biomedicines11082195.


Partial Nephrectomy, a Comparison between Different Modalities: A Tertiary Care Center Experience.

Al Asker A, Addar A, Alghamdi M, Alawad S, Alharbi M, Hamri S J Kidney Cancer VHL. 2021; 8(2):34-39.

PMID: 34178584 PMC: 8215000. DOI: 10.15586/jkcvhl.v8i2.179.


A 25 year perspective on the evolution and advances in an understanding of the biology, evaluation and treatment of kidney cancer.

Geynisman D, Maranchie J, Ball M, Bratslavsky G, Singer E Urol Oncol. 2021; 39(9):548-560.

PMID: 34092483 PMC: 9030590. DOI: 10.1016/j.urolonc.2021.04.038.


Temporal Trends in Selecting Patients for Partial Nephrectomy for Small Renal Cell Carcinomas in Alberta, Canada.

Tilley D, Remondini T, Van Tuyl J, Pak W, Gotto G Res Rep Urol. 2020; 12:85-90.

PMID: 32185151 PMC: 7061720. DOI: 10.2147/RRU.S212584.


Ischemia Techniques in Nephron-sparing Surgery: A Systematic Review and Meta-Analysis of Surgical, Oncological, and Functional Outcomes.

Greco F, Autorino R, Altieri V, Campbell S, Ficarra V, Gill I Eur Urol. 2018; 75(3):477-491.

PMID: 30327272 PMC: 9084636. DOI: 10.1016/j.eururo.2018.10.005.